- Home
- FSBC vs BBNX Comparison
FSBC vs BBNX Comparison
Compare FSBC & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSBC
- BBNX
- Stock Information
- Founded
- FSBC 2002
- BBNX 2015
- Country
- FSBC United States
- BBNX United States
- Employees
- FSBC N/A
- BBNX N/A
- Industry
- FSBC Banks
- BBNX Medical/Dental Instruments
- Sector
- FSBC Finance
- BBNX Health Care
- Exchange
- FSBC Nasdaq
- BBNX Nasdaq
- Market Cap
- FSBC 628.9M
- BBNX 740.7M
- IPO Year
- FSBC 2021
- BBNX 2025
- Fundamental
- Price
- FSBC $32.85
- BBNX $22.47
- Analyst Decision
- FSBC Buy
- BBNX Strong Buy
- Analyst Count
- FSBC 5
- BBNX 10
- Target Price
- FSBC $34.80
- BBNX $25.10
- AVG Volume (30 Days)
- FSBC 33.5K
- BBNX 993.8K
- Earning Date
- FSBC 10-27-2025
- BBNX 11-06-2025
- Dividend Yield
- FSBC 2.42%
- BBNX N/A
- EPS Growth
- FSBC 2.40
- BBNX N/A
- EPS
- FSBC 2.44
- BBNX N/A
- Revenue
- FSBC $132,133,000.00
- BBNX $78,022,000.00
- Revenue This Year
- FSBC $31.83
- BBNX $42.80
- Revenue Next Year
- FSBC $15.58
- BBNX $34.58
- P/E Ratio
- FSBC $13.55
- BBNX N/A
- Revenue Growth
- FSBC 18.01
- BBNX 550.45
- 52 Week Low
- FSBC $22.22
- BBNX $8.89
- 52 Week High
- FSBC $35.13
- BBNX $26.66
- Technical
- Relative Strength Index (RSI)
- FSBC 55.00
- BBNX 57.83
- Support Level
- FSBC $32.41
- BBNX $21.97
- Resistance Level
- FSBC $33.87
- BBNX $23.61
- Average True Range (ATR)
- FSBC 0.94
- BBNX 1.61
- MACD
- FSBC -0.07
- BBNX -0.34
- Stochastic Oscillator
- FSBC 49.29
- BBNX 39.28
About FSBC Five Star Bancorp
Five Star Bancorp is a bank holding company through its subsidiary it operates in California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment; Banking.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.